drugset / Trial / NCT01258712
Study of Tocilizumab in Combination With Methotrexate for Treatment of Moderate to Severe Rheumatoid Arthritis Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a Phase III study to evaluate efficacy and safety of Tocilizumab in patients with Rheumatoid Arthritis.
Timeline
- Start
- 2010-12
- Primary completion
- 2012-10
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tocilizumab | Monoclonal antibody | 8 mg/kg | Intravenous |
| Background | Methotrexate | Small molecule | 10 mg | — |
| Background | Methotrexate | Small molecule | 20 mg | — |